Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.
They agreed to continue technical exchanges to help end the epidemic worldwide as soon as possible, it said.
Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.
Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in the Phase 3 clinical trials.
The health ministry on Saturday recommended the use of antiviral drug remdesivir in moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.
The PMO said mass yoga demonstrations will be organised at 75 iconic locations across the country under the leadership of 75 Union ministers, with Modi attending the exercise at Mysore.
Charpentier, 51, and Doudna, 56, are just the sixth and seventh women to win the Nobel Prize in chemistry, according to France 24.
Major Beena Tiwari was the only woman in the 99-member medical team at the Indian Army's field hospital in earthquake-hit Turkey.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
The decline in the effectiveness of Covaxin, India's indigenous COVID-19 vaccine, from 77.8 per cent to 50 per cent during a Delta-driven case surge in April and May this year is neither bad nor surprising, say scientists.
Commercial launch and supply to major government and private hospitals is expected in mid-June.
'We need to prove to the world that quality vaccines and R&D are possible in India.'
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.
'We believe that India is capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have'
Food (ahara) and lifestyle (vihara) have a major impact on the health of your heart.
Essentially a message movie, Jayeshbhai Jordaar masks its horror in humour to play out like an on-the-run road trip, observes Sukanya Verma.
The renowned pulmonologist, who was part of the national COVID task force, highlighted the need for research on developing vaccines which will cover not only the current circulating strains but also from the emerging variants.
The National Clinical Registry for COVID-19 will collect systematic data on clinical signs and symptoms, laboratory investigations, management protocols, the clinical course of COVID-19, disease spectrum and outcomes of patients.
The country saw a reduction in the number of swine flu cases due to masks and sanitation practices.
The White House described the development as "quite good news".
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
He expressed hope that India will soon have indigenous production of vaccine against coronavirus.
Studies in China claim that traditional Chinese medicines seem to be working effectively on patients with mild or moderate symptoms of coronavirus.
Nothing exemplifies this Sikh khundak (revenge) better than the fact that all the tallest names in the state lost their election to novices fielded by AAP.
In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.
The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.
The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.
According to a gazette notification of the draft rules published on June 5, a hospital or medical institution may import new drug for 'compassionate use for treatment of patients suffering from life threatening disease or disease causing serious permanent disability or disease requiring therapy for unmet medical need', which has not been permitted in the country, but under Phase-III clinical trial (human trial) in the country or abroad, by making an application to the Central Drug Regulator.
India's COVID-19 recovery rate rose to 63.13 per cent on Wednesday with a record 28,472 patients recuperating from the disease in 24 hours, while the case fatality rate further dropped to 2.41 per cent, the Union health ministry said.
Sebamed's campaign for its cleansing bar of the same name, released across print, television, digital and outdoor, has also named Santoor, a popular soap brand from Wipro Consumer Care.
The country has reported the highest number of recoveries with 42,08,431 COVID-19 patients having recovered from the disease so far, pushing the national recovery rate to nearly 80 per cent, while the case fatality rate has further dropped to 1.61 per cent, the ministry said.
As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.
Chairperson of the COVID Task Force for All India Institute of Medical Sciences, Dr Naveet Wig on Thursday said that the COVID-19 crisis is 'a dynamic situation' and to prevent a third wave of the pandemic, there is a need to keep changing strategies.
'The prioritisation of groups for COVID-19 vaccine shall be based on two key considerations -- occupational hazard and risk of exposure to infection, and the risk of developing severe disease and increased mortality'
The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials.
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.
'India has registered the highest recoveries in a single day. 68,584 COVID-19 patients have recovered and been discharged in the last 24 hours. 'This has led to a surge in the total number of recovered patients which is nearly 30 lakh (2,970,492). 'With this, India's Recovery Rate amongst the COVID-19 patients has crossed 77 per cent (77.09 per cent), the govt said.
The complaint seeking registration of a first information report on cheating, criminal conspiracy and other charges was filed in the court of Chief Judicial Magistrate Mukesh Kumar here on Tuesday by Tamanna Hashmi, who identifies himself as a social worker and is often in news for his numerous court complaints against politicians over various issues.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances